Cementless Total Knee Arthroplasty Market Size & Share, by Type (Primary, Revision), End User (Hospitals, Home Healthcare, Ambulatory Surgery Centers) - Global Supply & Demand Analysis & Growth Forecasts, Statistics Report 2024-2036

  • Report ID: 5395
  • Published Date: Nov 24, 2023
  • Report Format: PDF, PPT

Global Market Size, Forecast, and Trend Highlights Over 2024-2036

Cementless Total Knee Arthroplasty Market size is anticipated to reach USD 20 billion by the end of 2036, growing at a CAGR of 8% during the forecast period, i.e., 2024-2036. In the year 2023, the industry size of cementless total knee arthroplasty was over USD 10 billion. The rising prevalence of knee osteoarthritis is one of the primary growth factors of the market. According to the Centers for Disease Control and Prevention (CDC) osteoarthritis affects more than 500 million which is about 7% of the world’s population.

The cementless total knee arthroplasty market refers to the medical devices and surgical procedures related to knee replacement surgeries that do not involve the use of bone cement to secure the artificial components in the patient's knee joint. Cementless TKA is an alternative approach to traditional knee replacement surgery, where bone cement is used to fix the prosthesis in place. Cementless TKA has gained popularity for several reasons, including its potential to provide better long-term implant stability and reduce the risk of complications associated with cemented TKA. Ongoing research and clinical studies are conducted to assess the long-term outcomes and benefits of cementless TKA. This research informs clinical practice and helps in the development of improved implant designs.


Cementless Total Knee Arthroplasty Market
Get more information on this report: Request Free Sample PDF


Cementless Total Knee Arthroplasty Market: Key Insights

Base Year

2023

Forecast Year

2024-2036

CAGR

~8%

Base Year Market Size (2023)

~ USD 10 Billion

Forecast Year Market Size (2036)

~ USD 20 Billion

Regional Scope

  • North America (U.S., and Canada)
  • Latin America (Mexico, Argentina, Rest of Latin America)
  • Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific)
  • Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of Middle East and Africa)
Get more information on this report: Request Free Sample PDF

Cementless Total Knee Arthroplasty Market: Growth Drivers and Challenges

Market-Growth-Drivers

Growth Drivers

  • Aging Population and Increased Prevalence of Osteoarthritis: As people age, the risk of developing degenerative joint conditions like osteoarthritis increases significantly. Osteoarthritis is a leading cause of knee pain and disability. According to the World Health Organization (WHO), osteoarthritis affects more than 303 million people worldwide, making it a major contributor to the global burden of disease. As the population continues to age, the demand for knee replacement surgeries, including cementless TKA, is expected to grow.
  • Rising Research and Clinical Studies: Ongoing research and clinical studies are conducted to assess the long-term outcomes and benefits of cementless TKA. These studies provide valuable insights into the effectiveness and safety of cementless TKA implants. As more data becomes available, it informs clinical practice and helps in the development of improved implant designs. Surgeons and patients can make more informed decisions based on evidence from these studies.
  • Regulatory Environment and Quality Assurance: Regulatory bodies such as the Food and Drug Administration (FDA) in the United States and the CE Mark in Europe play a crucial role in ensuring the safety and efficacy of cementless TKA implants. Compliance with these regulations is vital for manufacturers. However, a well-established regulatory framework can also foster trust among surgeons and patients. The aging population, increasing prevalence of osteoarthritis, patient preferences, and advancements in technology all contribute to the growth of this market. Market competition and innovation play a pivotal role in pushing the boundaries of what is possible in cementless TKA. Cost considerations and the potential for long-term cost savings make cementless TKA an attractive option for both patients and healthcare providers. Regulatory oversight and ongoing research ensure quality and safety in the field.

Challenges

  • Reimbursement Issues: The cost of TKA procedures, including cementless TKA, can be significant. Insurance coverage and reimbursement policies can vary widely, and patients may face challenges in accessing the procedure due to cost constraints. Healthcare providers and patients often struggle with navigating complex reimbursement systems. Insurance coverage for cementless TKA can vary significantly based on the type of insurance plan, location, and individual policy terms. While some private health insurance plans may cover a substantial portion of the costs, others may provide limited coverage or require high deductibles and copayments. Additionally, patients with public insurance programs, such as Medicare and Medicaid, may experience differences in coverage depending on state regulations.
  • Lack of knowledge regarding the new technology of cementless total knee anthroplasty surgery
  • Increased cost of the recently developed features in the surgery


Cementless Total Knee Arthroplasty Segmentation

Type (Primary, Revision)

The primary cementless TKA segment is estimated to hold 60% share of the global cementless total knee arthroplasty market in the year 2036. The global primary cementless TKA segment is experiencing substantial growth due to a combination of demographic changes, lifestyle factors, technological advancements, patient awareness, surgeon preferences, market competition, regulatory oversight, and ongoing innovation. These factors collectively contribute to the expansion of primary cementless TKA as a preferred solution for addressing knee joint problems and enhancing the quality of life for patients worldwide.

Stringent regulatory requirements for medical devices exist in many countries to ensure the safety and efficacy of cementless TKA implants. A robust regulatory framework fosters trust among surgeons, patients, and healthcare systems. This trust, in turn, contributes to the growth of the global primary cementless TKA market. Information about regulatory frameworks and approvals for medical devices can be obtained from the websites of relevant regulatory agencies in different countries. For example, the Food and Drug Administration (FDA) in the United States and the European Medicines Agency (EMA) in Europe provide information on regulatory requirements and approvals.

End User (Hospitals, Home Healthcare, Ambulatory Surgery Centers)

Cementless total knee arthroplasty market from the hospitals segment is expected to garner a significant share in the year 2036. Osteoarthritis is a leading indication for primary cementless TKA procedures, and its prevalence is rising. This condition results in pain, reduced mobility, and functional limitations, leading to a greater demand for surgical interventions in hospital settings. The World Health Organization (WHO) reports that osteoarthritis is the most common form of arthritis and is a significant cause of pain and disability worldwide. As the prevalence of osteoarthritis continues to increase, the demand for primary cementless TKA procedures in hospitals grows accordingly. Rehabilitation is an integral part of the recovery process for patients undergoing primary cementless TKA. Hospitals are equipped to provide comprehensive rehabilitation services, including physical therapy, to help patients regain mobility and function after surgery. The availability of these services contributes to the success of primary cementless TKA in hospital settings.

Our in-depth analysis of the global market includes the following segments:

                             Type

  • Primary
  • Revision

                             End User

  • Hospitals
  • Home Healthcare
  • Ambulatory Surgery Centers

Want to customize this research report as per your requirements? Our research team will cover the information you require to help you take effective business decisions.

Customize this Report

Cementless Total Knee Arthroplasty Industry - Regional Synopsis

APAC Market Forecast

The cementless total knee arthroplasty market in the Asia Pacific region is projected to hold the largest market share of 38% by the end of 2036. The cementless TKA market in the Asia Pacific region is experiencing significant growth due to a combination of demographic changes, lifestyle factors, technological advancements, surgeon expertise, patient awareness, regulatory compliance, and the availability of specialized orthopedic centers. These drivers collectively contribute to the success of cementless TKA as a preferred solution for addressing knee joint problems and improving the quality of life for patients in the Asia Pacific region.

Specialized orthopedic centers and hospitals in the Asia Pacific region provide focused care for joint-related conditions, including cementless TKA. The presence of these centers ensures that patients have access to specialized expertise and advanced surgical techniques. Reports and publications on healthcare infrastructure in Asia Pacific countries often highlight the role of specialized orthopedic centers in addressing joint conditions and performing joint replacement procedures. These centers are significant drivers for the growth of cementless TKA in the region.

North American Market Statistics

The cementless total knee arthroplasty market in the North America region is projected to hold the second largest share during the forecast period. Continuous advancements in implant design, materials, and surgical techniques have significantly improved the success and longevity of cementless TKA in North America. Innovative materials, such as highly cross-linked polyethylene and advanced metal alloys, have reduced wear rates, enhanced implant stability, and extended implant lifespan. Information about the latest advancements in cementless TKA implants and technologies is often published in academic journals, industry reports, and on the websites of leading medical device manufacturers. These innovations have had a substantial impact on the success of cementless TKA procedures in North America. Obesity is a significant risk factor for osteoarthritis and knee joint problems, making it a noteworthy growth driver in North America. The region has seen an increase in obesity rates due to changes in lifestyle, which contributes to the need for joint replacement procedures, including cementless TKA. The CDC and Health Canada provide data on obesity rates and their implications for public health in North America. According to the Centers for Disease Control and Prevention (CDC), in the United States, the prevalence of obesity has been steadily increasing over the years. In 2019-2020, the age-adjusted prevalence of obesity among adults was approximately 42.4%. This means that almost 4 out of 10 adults in the U.S. were considered obese.

Research Nester
Cementless Total Knee Arthroplasty Market size
Get more information on this report: Request Free Sample PDF

Companies Dominating the Cementless Total Knee Arthroplasty Landscape

top-features-companies
    • Zimmer Biomet Holdings, Inc.
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Stryker Corporation
    • Johnson & Johnson (DePuy Synthes)
    • Smith & Nephew plc
    • Medtronic plc (formerly known as Covidien)
    • Conformis, Inc.
    • LimaCorporate S.p.A.
    • Exactech, Inc.
    • Corin Group
    • MatOrtho Ltd.

In-the-news

In The News

  • Stryker acquired Vocera Communications, a US-based healthcare communications company, for USD 3.09 billion. The acquisition expanded Stryker's portfolio of digital healthcare solutions and technologies.
  • Stryker acquired K2M Group Holdings, a US-based spinal medical device company, for USD 1.4 billion. The acquisition expanded Stryker's portfolio of spinal medical devices and solutions.

Author Credits:  Radhika Gupta, Shivam Bhutani


  • Report ID: 5395
  • Published Date: Nov 24, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Increasing aging population is the major factor driving the market growth.

The market size of cementless total knee arthroplasty is anticipated to attain a CAGR of 8% over the forecast period, i.e., 2024-2036.

The major players in the market Zimmer Biomet Holdings, Inc., Stryker Corporation, Johnson & Johnson (DePuy Synthes), Smith & Nephew plc, Medtronic plc (formerly known as Covidien), Conformis, Inc., and others.

The hospitals segment is anticipated to garner the largest market size by the end of 2036 and display significant growth opportunities.

The market in the Asia Pacific region is projected to hold the largest market share by the end of 2036 and provide more business opportunities in the future.
Cementless Total Knee Arthroplasty Market Report Scope
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying